Skip to content

Frontlight ResearchEarly access

Trial site

Kantonsspital Graubuenden (Site 0091)

Chur, Kanton Graubünden 7000, SwitzerlandNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Melanoma

Closed trials

Completed
Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)
NCT03820986· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Kantonsspital Graubuenden (Site 0091): trial site – Frontlight Research